University of Iowa Health Care researchers have been awarded a five-year, $10.7 million Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute to study new, targeted therapies for neuroendocrine tumors (NETs), which are rare, slow-growing cancers that can arise almost anywhere in the body.